Francesca Montanari, MD

Dr. Francesca Montanari is an Assistant Professor of Medicine and Experimental Therapeutics in the Center for Lymphoid Malignancies with an appointment to the Division of Hematology/Oncology and the Division of Experimental Therapeutics at the Columbia University College of Physicians and Surgeons and the New York-Presbyterian Hospital in New York City.

Dr. Montanari obtained her Medical Doctorate and completed her training in hematology in Italy, where she conducted several clinical trials focused on investigating various aspects of the less common low grade lymphoproliferative disorders, in particular marginal zone lymphomas subtypes. She also participated in clinical trials evaluating new therapeutic platforms in follicular lymphomas, incorporating strategies to decrease the risk of post autologous stem cell transplant relapse.

Subsequently in the United States, Dr. Montanari focused her research on post-transplant lymphoproliferative disorders, creating one of the world's largest data sets of these diseases; the analysis of which, comprising clinical and pathological characteristics at initial presentation and in relapse, has led to the development of a new prognostic scoring system. 

She then completed her Residency in Internal Medicine and Fellowship in Hematology and Medical Oncology at the New York University Langone Medical Center, where she was part of the Faculty prior to joining the Center of Lymphoid Malignancies at Columbia University Medical Center.

With over 15 years of clinical and research experience in lymphomas, Dr. Montanari’s interest focuses on improving and deepening the knowledge of the less common and less characterized subtypes of lymphomas, on prognostication and on developing therapeutic platforms (lymphoma subtype specific), leveraging developments in biology, biomarkers and novel agents.

Dr. Montanari is a member of the American Society of Hematology and American Society of Clinical Oncology.